'Game-Changer' Pfizer Pill Is Easier to Find as Omicron Fades Away

As the omicron wave peaked in the U.S. last month, the first-line treatment for high-risk patients with early Covid dangled out of reach for most. Only a trickle of the new Paxlovid pill from Pfizer Inc. was reaching hospitals and pharmacies. Now, as cases plummet nationwide and the company continues to deliver hundreds of thousands of doses ordered by the federal government to pharmacies, Paxlovid is starting to look downright plentiful. Doctors and health officials in New York, Boston, Colorado and other areas where the omicron wave has receded report that supply seems to be meeting the softening demand. “We’ve seen such a rapid decline in Covid cases that it’s not as needed anymore,” said Asif Merchant, who chairs the Massachusetts Medical Society’s committee on geriatrics. “Having the availability three or four weeks ago would have made a tremendous amount of difference.”